secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2023-01-27T23:59:59+00:00
Accession:  0001193125-23-016833
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q4 net income $2.08B ($7.28 EPS); revenue $15.5B; new $3B buyback
--------------------------------------------------------------------------------

- Q4 revenue $15.50B (+2.9% YoY); net income $2.08B ($7.28 diluted EPS) incl $1.33B facility-sale gains.
- Adjusted EBITDA $3.18B vs $3.15B YoY; same-facility admissions +2.9%, ER visits +11.4%.
- FY2022 revenue $60.23B, net income $5.64B ($19.15 EPS); adjusted EBITDA $12.07B.
- Board authorized new $3B share repurchase program; declared quarterly dividend of $0.60/sh payable Mar 31.
- 2023 guidance: revenue $61.5-63.5B, EPS $16.40-17.60, capex ~$4.3B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312523016833/0001193125-23-016833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312523016833/d268135d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-016833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer